Sickle Cell DiseaseSymptoms, Doctors, Treatments, Advances & More
Sickle Cell Disease Overview
Learn About Sickle Cell Disease
Duke Adult Comprehensive Sickle Cell Center - Clinic 2N
John Strouse is a Hematologist and a Pediatrics provider practicing medicine in Durham, North Carolina. Dr. Strouse is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Thrombectomy, and Bone Marrow Aspiration. Dr. Strouse is board certified in American Board Of Internal Med, Hematology , American Board Of Pediatrics, Pediatric Hematology-Oncology, and American Board Of Pediatrics, General Pediatrics . Dr. Strouse is currently accepting new patients.
Duke Adult Comprehensive Sickle Cell Center - Clinic 2N
Nirmish Shah is a Hematologist and a Pediatrics provider practicing medicine in Durham, North Carolina. Dr. Shah is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Shah is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
Markus Mapara is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Mapara is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Mapara is board certified in Hematology and Medical Oncology. Dr. Mapara is currently accepting new patients.
Summary: This study is being done to see if the study drug, motixafortide, is safe in participants with sickle cell disease (SCD). Investigators also want to see if the drug will help the body increase the number of stem cells that can be collected for possible future transplant use. PRIMARY OBJECTIVE * To characterize the safety and tolerability of motixafortide in participants with SCD as determined by t...
Background: Blood disorders like sickle cell disease and malaria affect many people around the world. Researchers want to learn more about blood disorders. To do this, they need to collect biological samples from people with blood disorders. They also need to collect samples from healthy people.


